Harvard Medical School Fails to Control Drug Industry Money

Arguably the top medical school in the country, Harvard Medical School received an "F" by the American Medical Student Association in monitoring drug industry money contributed to the university. This is a major problem because drug companies could be slipping money under the table to professors who promote their medication. This unethical behavior should not be tolerated by a prestigious school like Harvard.

The New York Times reported that earlier today Senator Grassley wrote a letter to Harvard asking for details about payments made to over 100 faculty members at Harvard Medical School. In the article, Grassley talks about how three Harvard psychiatrists failed to report at least $4.2 million in payments between 2000-2007.

It is a scary situation to think that professors are getting incentives by drug companies to promote their product, especially with an industry leader like Harvard at fault. This further proves the large extent of control that major pharmaceutical manufacturers have in the health care field. Hopefully Harvard will be able to get all of this straightened out within the next couple years, or its status as a prestigious medical institution could go down the drain.